UNITED THERAPEUTICS Corp financial data

Symbol
UTHR on Nasdaq
Location
1000 Spring St, Silver Spring, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 428 % -42.4%
Quick Ratio 15.3 % -33.9%
Debt-to-equity 19 % -21%
Return On Equity 19.2 % +12.3%
Return On Assets 16.2 % +17.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.6M shares -5%
Common Stock, Shares, Outstanding 44.6M shares -5.04%
Entity Public Float 9.14B USD -13.2%
Common Stock, Value, Issued 700K USD 0%
Weighted Average Number of Shares Outstanding, Basic 44.6M shares -4.9%
Weighted Average Number of Shares Outstanding, Diluted 48.4M shares -2.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.76B USD +25%
Research and Development Expense 499M USD +42.3%
Costs and Expenses 1.48B USD +33.8%
Operating Income (Loss) 1.28B USD +16.3%
Nonoperating Income (Expense) 159M USD +177%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.44B USD +24.2%
Income Tax Expense (Benefit) 327M USD +26.8%
Net Income (Loss) Attributable to Parent 1.11B USD +23.5%
Earnings Per Share, Basic 24.3 USD/shares +26%
Earnings Per Share, Diluted 22.7 USD/shares +25.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.55B USD +40.3%
Marketable Securities, Current 1.77B USD +0.27%
Accounts Receivable, after Allowance for Credit Loss, Current 342M USD +32.2%
Inventory, Net 147M USD +40.7%
Other Assets, Current 185M USD -15.9%
Assets, Current 4B USD +15.7%
Deferred Income Tax Assets, Net 391M USD +20.1%
Property, Plant and Equipment, Net 1.16B USD +16.6%
Operating Lease, Right-of-Use Asset 12.2M USD
Goodwill 33.7M USD +20.4%
Other Assets, Noncurrent 184M USD +29.6%
Assets 7.12B USD +1.42%
Accounts Payable, Current 5.6M USD +36.6%
Employee-related Liabilities, Current 72.9M USD +9.62%
Accrued Liabilities, Current 292M USD +29.5%
Liabilities, Current 873M USD +17.4%
Other Liabilities, Noncurrent 149M USD +121%
Liabilities 1.02B USD -22.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 7.4M USD
Retained Earnings (Accumulated Deficit) 6.92B USD +19.1%
Stockholders' Equity Attributable to Parent 6.1B USD +6.81%
Liabilities and Equity 7.12B USD +1.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 377M USD +0.45%
Net Cash Provided by (Used in) Financing Activities -1.07B USD -2298%
Net Cash Provided by (Used in) Investing Activities 735M USD
Common Stock, Shares Authorized 245M shares 0%
Common Stock, Shares, Issued 74.8M shares +1.61%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 43.8M USD -78.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.55B USD +40.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.6M USD -3.82%
Deferred Tax Assets, Valuation Allowance 30.8M USD +37.5%
Deferred Tax Assets, Gross 468M USD +19.7%
Operating Lease, Liability 12.2M USD
Payments to Acquire Property, Plant, and Equipment 38.2M USD -7.51%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.16B USD +23.6%
Lessee, Operating Lease, Liability, to be Paid 32.8M USD +3.47%
Property, Plant and Equipment, Gross 1.63B USD +15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.3M USD +22.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.7M USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.2M USD +20%
Deferred Tax Assets, Operating Loss Carryforwards 21.4M USD +125%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 24.1M USD +58.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.2M USD +20%
Depreciation, Depletion and Amortization 15M USD +12.8%
Deferred Tax Assets, Net of Valuation Allowance 437M USD +18.6%
Share-based Payment Arrangement, Expense 134M USD +53%
Interest Expense 58.8M USD +41.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%